Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

NCT00571467 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to recruitment not meeting expectations.

Conditions

Idiopathic Thrombocytopenic Purpura (ITP)

Interventions

DRUG: PRTX-100 (Staphylococcal protein A)

Sponsor

Protalex, Inc.